Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Neurogene Inc.(NGNE) | 994,229 | 1,004,291 | +10,062 | $19.27M | $51.12M | 7.97% | +$31.85M |
| Alpine Immune Sciences Inc | 3,703,433 | 1,128,499 | -2,574,934 | $70.59M | $44.73M | 6.97% | -$25.85M |
| UroGen Pharma Ltd.(URGN) | 2,620,545 | 2,620,545 | 0 | $39.31M | $39.31M | 6.13% | $0 |
| ABIVAX Société AnonymeADS(ABVX) | 1,550,000 | 2,488,483 | +938,483 | $16.59M | $35.59M | 5.55% | +$19.00M |
| Evolus, Inc.(EOLS) | 2,000,000 | 2,450,000 | +450,000 | $21.06M | $34.30M | 5.35% | +$13.24M |
| Pliant Therapeutics, Inc.(PLRX) | 1,823,184 | 1,851,864 | +28,680 | $33.02M | $27.59M | 4.30% | -$5.43M |
| Apogee Therapeutics Inc | 400,000 | 400,000 | 0 | $11.18M | $26.58M | 4.14% | +$15.40M |
| Aerovate Therapeutics Inc | 1,037,690 | 887,690 | -150,000 | $23.48M | $26.25M | 4.09% | +$2.77M |
| Viridian Therapeutics, Inc.(VRDN) | 0 | 1,335,000 | +1,335,000 | $0 | $23.38M | 3.64% | +$23.38M |
| Anaptysbio Inc | 976,981 | 976,981 | 0 | $20.93M | $22.00M | 3.43% | +$1.07M |
| Esperion Therapeutics Inc Ne | 0 | 8,000,000 | +8,000,000 | $0 | $21.44M | 3.34% | +$21.44M |
| Insmed Incorporated(INSM) | 225,912 | 775,585 | +549,673 | $7.00M | $21.04M | 3.28% | +$14.04M |
| Arcellx Inc COMMON STOCK | 48,264 | 300,000 | +251,736 | $2.68M | $20.86M | 3.25% | +$18.19M |
| Xenon Pharmaceuticals Inc.(XENE) | 600,000 | 456,148 | -143,852 | $27.64M | $19.64M | 3.06% | -$8.00M |
| Mind Medicine Mindmed Inc | 0 | 2,000,000 | +2,000,000 | $0 | $18.80M | 2.93% | +$18.80M |
| Dianthus Therapeutics, Inc.(DNTH) | 0 | 625,000 | +625,000 | $0 | $18.75M | 2.92% | +$18.75M |
| Outlook Therapeutics, Inc.(OTLK) | 0 | 1,480,000 | +1,480,000 | $0 | $17.67M | 2.75% | +$17.67M |
| Amicus Therapeutics Inc COM | 1,280,500 | 1,495,500 | +215,000 | $18.17M | $17.62M | 2.75% | -$553.3K |
| Ocular Therapeutix, Inc.(OCUL) | 700,000 | 1,728,723 | +1,028,723 | $3.12M | $15.73M | 2.45% | +$12.61M |
| Dynavax Technologies Corp | 0 | 1,264,920 | +1,264,920 | $0 | $15.70M | 2.45% | +$15.70M |
| Cytokinetics, Incorporated(CYTK) | 500,000 | 202,202 | -297,798 | $41.74M | $14.18M | 2.21% | -$27.57M |
| Optinose Inc | 8,839,939 | 8,786,318 | -53,621 | $11.40M | $12.83M | 2.00% | +$1.42M |
| Jasper Therapeutics, Inc.(JSPR) | 0 | 407,550 | +407,550 | $0 | $11.97M | 1.86% | +$11.97M |
| Intra-Cellular Therapies Inc | 110,607 | 150,000 | +39,393 | $7.92M | $10.38M | 1.62% | +$2.46M |
| Merus N V | 20,000 | 223,288 | +203,288 | $550.0K | $10.05M | 1.57% | +$9.50M |
| Vistagen Therapeutics, Inc.(VTGN) | 1,858,735 | 1,858,735 | 0 | $9.55M | $9.81M | 1.53% | +$260.2K |
| Terns Pharmaceuticals Inc | 1,309,975 | 1,309,975 | 0 | $8.50M | $8.59M | 1.34% | +$91.7K |
| Immunocore Holdings plcADS(IMCR) | 293,000 | 115,000 | -178,000 | $20.02M | $7.47M | 1.16% | -$12.54M |
| Autolus Therapeutics plcADS(AUTL) | 0 | 1,166,667 | +1,166,667 | $0 | $7.44M | 1.16% | +$7.44M |
| Puma Biotechnology, Inc.(PBYI) | 1,093,273 | 1,343,628 | +250,355 | $4.73M | $7.12M | 1.11% | +$2.39M |
| Zura Bio LimitedCL A(ZURA) | 3,295,000 | 2,757,740 | -537,260 | $15.39M | $7.09M | 1.10% | -$8.30M |
| Helix Acquisition Corp IiCL A | 0 | 500,000 | +500,000 | $0 | $5.20M | 0.81% | +$5.20M |
| Spyre Therapeutics, Inc.(SYRE) | 125,000 | 125,000 | 0 | $2.69M | $4.74M | 0.74% | +$2.05M |
| Kyverna Therapeutics, Inc.(KYTX) | 0 | 150,000 | +150,000 | $0 | $3.73M | 0.58% | +$3.73M |
| Arvinas, Inc.(ARVN) | 234,082 | 71,113 | -162,969 | $9.63M | $2.94M | 0.46% | -$6.70M |
| Alkermes plcSHS(ALKS) | 875,044 | 0 | -875,044 | $24.27M | $0 | — | -$24.27M |
| Axsome Therapeutics, Inc.(AXSM) | 4,963 | 0 | -4,963 | $395.0K | $0 | — | -$395.0K |
| Karuna Therapeutics Inc | 30,250 | 0 | -30,250 | $9.57M | $0 | — | -$9.57M |
| Mural Oncology Pub Ltd Co | 11,509 | 0 | -11,509 | $68.1K | $0 | — | -$68.1K |
| Rapt Therapeutics Inc | 1,099,753 | 0 | -1,099,753 | $27.33M | $0 | — | -$27.33M |
| Sarepta Therapeutics, Inc.(SRPT) | 80,000 | 0 | -80,000 | $7.71M | $0 | — | -$7.71M |
| Tourmaline Bio Inc | 672,885 | 0 | -672,885 | $17.62M | $0 | — | -$17.62M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 648,000 | 0 | -648,000 | $30.99M | $0 | — | -$30.99M |
| Vaxcyte, Inc.(PCVX) | 360,000 | 0 | -360,000 | $22.61M | $0 | — | -$22.61M |